{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:00Z","timestamp":1707524100897},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,7,7]]},"DOI":"10.7759\/cureus.9053","type":"journal-article","created":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T22:55:41Z","timestamp":1594162541000},"source":"Crossref","is-referenced-by-count":1,"title":["Extremely Late In-Stent Thrombosis 12 Years After Implantation of a Drug-Eluting Stent"],"prefix":"10.7759","author":[{"given":"Elsa","family":"Sleiman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rabih","family":"Tabet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Boutros","family":"Karam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ayad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Royzman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g3859","article-title":"Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis","volume":"348","author":"Windecker S","year":"2014","unstructured":"Windecker S, Stortecky S, Stefanini GG, et al.. Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis. BMJ. 2014, 348:3859. 10.1136\/bmj.g3859","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"35","author":"Kolh P","year":"2014","unstructured":"Kolh P, Windecker S, Alfonso F, et al.. 2014 ESC\/EACTS guidelines on myocardial revascularization: the Task Force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014, 35:2541-2619. 10.1093\/eurheartj\/ehu278","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore S","year":"2012","unstructured":"Bangalore S, Kumar S, Fusaro M, et al.. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials. Circulation. 2012, 125:2873-2891. 10.1161\/CIRCULATIONAHA.112.097014","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehr479","article-title":"Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR)","volume":"33","author":"Sarno G","year":"2012","unstructured":"Sarno G, Lagerqvist B, Fr\u00f6bert O, et al.. Lower risk of stent thrombosis and restenosis with unrestricted use of 'new-generation' drug-eluting stents: a report from the nationwide Swedish Coronary Angiography and Angioplasty Registry (SCAAR). Eur Heart J. 2012, 33:606-613. 10.1093\/eurheartj\/ehr479","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.14503\/THIJ-14-4550","article-title":"Very late stent thrombosis 11 years after implantation of a drug-eluting stent","volume":"42","author":"Liou K","year":"2015","unstructured":"Liou K, Jepson N. Very late stent thrombosis 11 years after implantation of a drug-eluting stent. Tex Heart Inst J. 2015, 42:487-490. 10.14503\/THIJ-14-4550","journal-title":"Tex Heart Inst J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.14744\/AnatolJCardiol.2018.57983","article-title":"Extremely late stent thrombosis after more than 7 years (2691 days) of sirolimus-eluting stent implantation","volume":"19","author":"Demirci D","year":"2018","unstructured":"Demirci D, Ersan Demirci D, Arslan \u015e. Extremely late stent thrombosis after more than 7 years (2691 days) of sirolimus-eluting stent implantation. Anatol J Cardiol. 2018, 19:287-288. 10.14744\/AnatolJCardiol.2018.57983","journal-title":"Anatol J Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip DE","year":"2007","unstructured":"Cutlip DE, Windecker S, Mehran R, et al.. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation. 2007, 115:2344-2351. 10.1161\/CIRCULATIONAHA.106.685313","journal-title":"Circulation"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.019071","article-title":"Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography","volume":"133","author":"Taniwaki M","year":"2016","unstructured":"Taniwaki M, Radu MD, Zaugg S, et al.. Mechanisms of very late drug-eluting stent thrombosis assessed by optical coherence tomography. Circulation. 2016, 133:650-660. 10.1161\/CIRCULATIONAHA.115.019071","journal-title":"Circulation"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.693739","article-title":"Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization","volume":"115","author":"Finn AV","year":"2007","unstructured":"Finn AV, Joner M, Nakazawa G, et al.. Pathological correlates of late drug-eluting stent thrombosis: strut coverage as a marker of endothelialization. Circulation. 2007, 115:2435-2441. 10.1161\/CIRCULATIONAHA.107.693739","journal-title":"Circulation"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner M","year":"2006","unstructured":"Joner M, Finn AV, Farb A, et al.. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006, 48:193-202. 10.1016\/j.jacc.2006.03.042","journal-title":"J Am Coll Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cce2.75","article-title":"Current knowledge on very late stent thrombosis","volume":"4","author":"Kafkas N","year":"2018","unstructured":"Kafkas N, Dragasis S. Current knowledge on very late stent thrombosis. Continuing Cardiology Education. 2018, 4:40-44. 10.1002\/cce2.75","journal-title":"Continuing Cardiology Education"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.06.022","article-title":"Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"244","author":"De Luca G","year":"2017","unstructured":"De Luca G, Smits P, Hofma SH, et al.. Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Int J Cardiol. 2017, 244:121-127. 10.1016\/j.ijcard.2017.06.022","journal-title":"Int J Cardiol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2019.01.234","article-title":"7-year outcomes of a randomized trial comparing the first-generation sirolimus-eluting stent versus the new-generation everolimus-eluting stent: the RESET trial","volume":"12","author":"Shiomi H","year":"2019","unstructured":"Shiomi H, Kozuma K, Morimoto T, et al.. 7-year outcomes of a randomized trial comparing the first-generation sirolimus-eluting stent versus the new-generation everolimus-eluting stent: the RESET trial. JACC Cardiovasc Interv. 2019, 12:637-647. 10.1016\/j.jcin.2019.01.234","journal-title":"JACC Cardiovasc Interv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2013.07.009","article-title":"5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions)","volume":"6","author":"Gada H","year":"2013","unstructured":"Gada H, Kirtane AJ, Newman W, et al.. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions). JACC Cardiovasc Interv. 2013, 6:1263-1266. 10.1016\/j.jcin.2013.07.009","journal-title":"JACC Cardiovasc Interv"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/MCA.0000000000000109","article-title":"Long-term risk of late and very late stent thrombosis in patients treated with everolimus against paclitaxel-eluting stents: an updated meta-analysis","volume":"25","author":"Li P","year":"2014","unstructured":"Li P, Liu JP. Long-term risk of late and very late stent thrombosis in patients treated with everolimus against paclitaxel-eluting stents: an updated meta-analysis. Coron Artery Dis. 2014, 25:369-377. 10.1097\/MCA.0000000000000109","journal-title":"Coron Artery Dis"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/36480-extremely-late-in-stent-thrombosis-12-years-after-implantation-of-a-drug-eluting-stent","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:27:34Z","timestamp":1707506854000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/36480-extremely-late-in-stent-thrombosis-12-years-after-implantation-of-a-drug-eluting-stent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,7]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.9053","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7,7]]}}}